Latest Market News

Trigg Minerals has secured a dual listing on the U.S. OTCQB market, enhancing accessibility for American investors and positioning itself for critical funding opportunities.

St Barbara Limited has announced its intention to separate its Atlantic Gold Operations in Nova Scotia, aiming to unlock value through a Canadian-led development while concentrating on its Papua New Guinea assets.

Vection Technologies has secured a three-year, AUD$575k partnership with global insurer Generali to deploy AI-driven extended reality solutions enhancing workplace safety and client engagement.

Finder Energy reports excellent progress on its Ikan 3D seismic reprocessing project, with imaging results exceeding expectations and the project on track for completion by end Q1 2025. The enhanced data aims to optimise development wells and de-risk exploration targets, potentially unlocking significant value.

IMDEX Limited has announced a fully franked ordinary dividend of AUD 0.015 per share, signaling steady shareholder returns for the half-year ending December 2024.

IMDEX reported a 10% revenue decline in 1H25 amid subdued global exploration activity but delivered a robust 28% increase in EBITDA, maintaining a strong 30% margin and positioning itself for growth.

IMDEX Limited reported resilient half-year results for FY2025, achieving half-on-half revenue growth and maintaining margins despite a challenging mining exploration environment. The company strengthened its balance sheet and declared an interim dividend, positioning itself for future growth.

IMDEX Limited reported a significant 84% increase in net profit for the half-year ended December 31, 2024, even as revenue declined by 10%. The company declared a steady interim dividend, underscoring confidence amid mixed financial signals.

Red Mountain Mining's recent desktop study of the Fry Lake Gold Project reveals promising gold mineralisation across multiple claims, setting the stage for an active 2025 exploration season amid soaring gold prices.

EMVision Medical Devices has secured US ethics approval for its pivotal multi-centre trial of the EMVision emu™ brain scanner, paving the way for a March 2025 trial start aimed at FDA clearance.

ASB reported a modest 1% increase in cash net profit after tax for the half-year ending December 2024, underpinned by rising lending volumes and strategic investments in housing and fraud prevention amid New Zealand's gradual economic recovery.

Suncorp Group Limited has announced a cash return of capital of AUD 3.00 per share, backed by shareholder and regulatory approvals, with payments scheduled for early March 2025.